Intended for healthcare professionals


Doctors advised to take special care with human albumin

BMJ 1999; 318 doi: (Published 19 June 1999) Cite this as: BMJ 1999;318:1643
  1. Richard Woodman
  1. London

    The Committee on Safety of Medicines has advised doctors to restrict the use of, and take special care when using, human albumin after concerns that far from saving life the preparation may actually increase mortality.

    A systematic review by the Cochrane Group published last year (BMJ 1998;317:253-40) of 23 randomised controlled trials, including 1419 critically ill patients with hypovolaemia, burns, and hypoalbuminaemia, found that the risk of death in the group treated with albumin was …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription